Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

older female patient and doctor

Sex, energy drinks and vaccines among the many topics planned for preventive cardiology conference

The three-day event will include sessions about sexual activity among heart patients, depression, energy drinks, stimulants, vaccines and more. The festivities begin Thursday, April 25, in Greece. 

April 22, 2024
meat-3139641_960_720.jpg

Keto diet ‘does not fulfill the criteria of a healthy diet,’ could be harmful for heart patients

The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time. 

April 19, 2024
Video of Alexander Fanaroff explaining the details of the BE ACTIVE trial that gamified fitness for cardiac patients. #ACC #ACC24 #ACC2024

Motivation helps heart patients stay active

Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active.

April 19, 2024
Foluso Fakorede, MD, interventional cardiologist, Cardiovascular Solutions of Central Mississippi, explains how he moved to rural Mississippi, the epicenter of the PAD and CLI epidemic, to open a practice to take action and reverse the glaring health disparities and that are leading to more than 400 leg amputations per day in the U.S.

Cardiologist moves to Mississippi to fight back against PAD and limit amputations

Interventional cardiologist Foluso Fakorede, MD, opened a practice in rural Mississippi, the epicenter of the PAD and CLI epidemic, to try and reverse the glaring health disparities in that region.

April 8, 2024
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

Weight loss drug semaglutide benefits obese patients presenting with HFpEF, type 2 diabetes

The new research, based on data from more than 600 patients, was presented at ACC.24 in Atlanta and published in the New England Journal of Medicine. Semaglutide is sold by Novo Nordisk under the brand name Wegovy.

April 7, 2024
alcoholshotdrink.jpg

Risk of heart disease skyrockets when young, middle-aged women regularly drink alcohol

"I wasn’t expecting these results among women in this lower age group, because we usually see increased risk for heart disease among older women," one cardiologist said. "It was definitely surprising.”

April 1, 2024
Medicare money payment

Medicare will now cover weight loss drug semaglutide if taken for heart benefits

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.

March 22, 2024

Intermittent fasting may increase risk of death from heart attack, stroke

Time-restricted eating is popular in the United States, but new research suggests it may do more harm than good if taken to certain extremes. 

March 18, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup